Publications
Research at the Leibniz Institute for Immunology focuses on the development of pioneering immune-cell therapies targeting cancer, autoimmune diseases, and chronic inflammation. While developments in this field are highly relevant within the medical community, they are also of great interest to the wider general public. The LIT has a comprehensive archive of international articles, publications, lectures, and online resources aimed at a variety of audiences. So, whoever you are, if you do not find what you are looking for, please do not hesitate to contact us.
Kronenberg K, Glehr G, Haehnel V, Dormann F, Pamler I, Preverin G, Arella F, Kapinsky M, Riquelme P, Offner R, Schlitt HJ, Beckhove P, Geissler EK, Burkhardt R, Hutchinson JA, Brosig A. Expanding the supply of human leukocytes for research by harvesting cell concentrates from Trima Accel tubing sets. Sci Rep. 2026 Aug 5. 16doi:10.1038/s41598-026-64945-3. PMID: 42557298
Harrer DC, Baldwin J, Barden M, Pan H, Gergely B, Szoor A, Vereb G, Herr W, Abken H. Augmenting CAR T cell functionality and metabolism through CD39 downtuning. Mol Ther Oncol. 2026 Sep 17. 34:201277. doi:10.1016/j.omton.2026.201277. PMID: 42440466
Bonifacius A, Mausberg P, Floegel F, Dragon AC, Tischer-Zimmermann S, Stoll S, Rahmati P, Spieler P, Lammoglia Cobo MF, Halenius A, Abken H, Blasczyk R, Nerreter T, Hudecek M, Schambach A, Hansmann L, Maecker-Kolhoff B, Eiz-Vesper B. Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies. Mol Ther Oncol. 2026 Sep 17. 34:201265. doi:10.1016/j.omton.2026.201265. PMID: 42440851
Perpinan E, Sompairac N, Marin Correa D, Ramon-Gil E, Man R, Camell-Raventos D, Savoldelli R, Fleming M, Bellersheim L, Santos CX, Elgosbi M, Lozano JJ, Maddaloni M, Schmidl C, Kodela E, Pique-Gili M, de Sande AH, Pinyol R, Higginbotham S, Peng Q, Landman E, Torres-Yaguana J, Sharma V, Zhang C, Kurt A et al. Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinoma. Nat Commun. 2026 Jul 13. doi:10.1038/s41467-026-73485-3. PMID: 42443155
Gallus C, Ayuk F, Beckhove P, Besser D, Bornhauser M, Buning H, Cantz T, Conrad C, Eichmuller S, Gazlig T, Graessner H, Gruters-Kieslich A, Huber N, Hudecek M, Kurz T, Lamprecht B, Luger E, Protzer U, Schambach A, Schafer R, Serrano P, Stegemann S, Stockert I, von Kalle C, Weber J et al. The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach. Hum Gene Ther. 2026 Jul 6.10430342261464845. doi:10.1177/10430342261464845. PMID: 42411062
Umland M, Dragon AC, Beermann LM, Bonifacius A, Kehler P, Gellert J, Blasczyk R, Abken H, Schambach A, Hudecek M, Eiz-Vesper B. Improved Antitumor Activity of Interleukin-12-Secreting Chimeric Antigen Receptor T Cells Targeting CD176 across Different Carcinomas. Transfus Med Hemother. 2026 Jun. 53:156–170. doi:10.1159/000549632. PMID: 41550609
Steinberg T, Angstwurm K, Fante MA, Herr W, Holler E, Edinger M, Linker R, Lee DH, Wolff D, Denk A. Proposal for Diagnostic Criteria for Manifestations of Chronic Graft-versus-Host Disease in Peripheral Nervous System and Muscles. Transplant Cell Ther. 2026 Jun. 32:697 e691–697 e613. doi:10.1016/j.jtct.2026.01.038. PMID: 41690553
Pohl S, Huber ML, Akamp T, Rosendahl A, Linnebank M, Schreiber L, Gebhard C, Strieder N, Rehli M, Buchalla W, Widbiller M. Molecular Signatures of Peripheral and Central Dental Pulp Subpopulations in Response to Streptococcus mutans: A Bulk RNA-Seq Analysis. Int Endod J. 2026 Jul. 59:1402–1415. doi:10.1111/iej.70117. PMID: 41731335
Gattinoni L, Inchingolo G, Harrer DC, Susana A, Puccio S, Slavkovic-Lukic D, Natrakul DA, Strieder N, Heuser-Loy C, Baldwin JG, Fioravanti J, Ji Y, Gautam S, Suriano C, Martin-Santos A, Schelker RC, Patel N, Mann J, Goff S, Mikkilineni L, Yang JC, Kwong MLM, Patel R, Rehli M, Highfill SL et al. Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse. Cell. 2026 Jun 11. 189:3686–3700 e3610. doi:10.1016/j.cell.2026.03.047. PMID: 42066750
de Blas A, Andreatta M, Antonana-Vildosola A, Velasco-Beltran P, Egia-Mendikute L, Jimenez-Lasheras B, Bosch A, Barreira-Manrique A, Oyenarte I, Lee SY, Heuser-Loy C, Baldwin JG, Schelker RC, Martin-Santos A, Mastrogiovanni F, Azkargorta M, Elortza F, Sutherland JD, Torrano V, Aransay AM, Perez-Gutierrez L, Gros A, Carmona SJ, Gattinoni L, Ereno-Orbea J et al. Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity. Cancer Res. 2026 Jun 15. 86:2896–2914. doi:10.1158/0008-5472.CAN-25-1246. PMID: 41886620